Victoria Smith

Yochanra® approved in China as world-first for FGFR inhibitor-resistant cancer

2026-08-07T12:17:00

This approval offers a potential new treatment approach for acquired resistance to FGFR inhibitors in advanced cholangiocarcinoma.